Carson Wealth (CWM LLC)
MBRX icon

Carson Wealth (CWM LLC)’s Moleculin Biotech MBRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1K Hold
1
– – ﹤0.01% 2820
2021
Q1 		$1K Buy
+1
New +$1.83K ﹤0.01% 2820
2020
Q4 		– Hold
0
– – – 2820
2020
Q3 		– Hold
0
– – – 2819
2020
Q2 		– Hold
0
– – – 2819
2020
Q1 		– Hold
0
– – – 2818
2019
Q4 		– Hold
0
– – – 2818
2019
Q3 		– Hold
0
– – – 2818
2019
Q2 		– Hold
0
– – – 2818
2019
Q1 		– Hold
0
– – – 2817

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Carson Wealth (CWM LLC)'s MBRX Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Moleculin Biotech (MBRX) position steady in Q2 2021 at 1 share worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2820.

Carson Wealth (CWM LLC) first reported a position in MBRX in Q1 2021 and has held it in 2 quarters since. 28 funds tracked by Wall St. Rank hold MBRX as of Q2 2021.

  • Carson Wealth (CWM LLC) held 1 share of Moleculin Biotech worth $1K as of Q2 2021.
  • Carson Wealth (CWM LLC) left its Moleculin Biotech share count unchanged in Q2 2021.
  • Moleculin Biotech made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #2820 holding.
  • Carson Wealth (CWM LLC) first reported a position in Moleculin Biotech in Q1 2021 and has held it in 2 quarters since.
  • 28 funds tracked by Wall St. Rank held Moleculin Biotech as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.